Bladder Cancer
FDA Approves PADCEV and Keytruda Perioperative Therapy: A Game-Changer for Cisplatin-Ineligible Bladder Cancer Patients
2025-11-27
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
AstraZeneca Voluntarily Withdraws Checkpoint Inhibitor Approved for Bladder Cancer Indication
2021-02-25
ASCO 2020: Maintenance Therapy with Avelumab Post-Chemo Improves Overall Survival of Bladder Cancer Patients
2020-05-29
LATEST
CDC Awards $3 Million to Louisiana Breast and Cervical Health Program for Cancer Screenings
2026-08-12
JAMA Pediatrics Study Finds Hospital-Wide Documentation of Curbside Consultations Improves Patient Safety
2026-08-12
iNaturalist Photographs Help Researchers Double Known Number of Harvestman Species Exhibiting Parental Care
2026-08-12
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia




